Analytical Data
-
基因名
IREM2
- Application
-
别名
CD300E; CD300LE; CLM2; CD300 Antigen Like Family Member E; CMRF35-Like Molecule 2; Polymeric immunoglobulin receptor 2
-
种属
Rat
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
D0V9T4
-
表达区间
Pro21~Met204
-
分子量
24kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IREM2 (Immunoregulatory Receptor Expressed on Myeloid Cells 2) is a member of the immunoglobulin superfamily and plays a crucial role in the immune response modulation, particularly within myeloid cells. The study of IREM2 has gained significance due to its potential involvement in various pathological conditions, including autoimmune diseases and cancer. Research indicates that IREM2 interacts with ligands, which can influence pro-inflammatory and anti-inflammatory signaling pathways, thus affecting immune cell activation and function. Understanding the mechanisms of IREM2's action could offer new insights into immune regulation and pave the way for novel therapeutic strategies. Recent advances in protein engineering and recombinant protein technology have enabled the production of functional IREM2 proteins, facilitating detailed studies of their structure, function, and interactions. As researchers delve deeper into the role of IREM2 in modulating immune responses, there is increasing interest in targeting this receptor as a means to improve immunotherapy approaches and enhance outcomes in diseases characterized by dysregulated immune responses.
